{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,12,16]],"date-time":"2023-12-16T00:19:20Z","timestamp":1702685960466},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T00:00:00Z","timestamp":1693785600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Aier Eye Hospital Group","award":["AM1901D1"],"award-info":[{"award-number":["AM1901D1"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Int Ophthalmol"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>To evaluate the safety of yttrium\u2013aluminum-garnet (YAG) laser vitreolysis for intraocular tissues.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>Thirty-six New Zealand rabbits were divided as follows: Group 1000 (n\u2009=\u200912) treated with YAG laser of 1000\u00a0mJ (5\u00a0mJ\u2009\u00d7\u2009200 shots), Group 2000 (n\u2009=\u200912) treated with YAG laser of 2000\u00a0mJ (5\u00a0mJ\u2009\u00d7\u2009400 shots), Group 3000 (n\u2009=\u200912) treated with YAG laser of 3000\u00a0mJ (5\u00a0mJ\u2009\u00d7\u2009600 shots). Either a single eye was chosen as the study eye in study groups while the other was untreated as the control group. Intraocular pressure (IOP), slit-lamp, optical coherence tomography (OCT), transmission electron microscopy (TEM), and inflammatory cytokines of aqueous humor (interleukin-1\u03b1 (IL-1\u03b1), interleukin-1\u03b2 (IL-1\u03b2), interleukin-8 (IL-8), and tumor necrosis factor-\u03b1 (TNF-\u03b1)) were performed to examine the rabbits.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>There were no abnormalities in the study groups of IOP, slit-lamp, and OCT examinations. Group 3000 of TEM showed: neutrophils and mitochondrial swelling on day 1, and fibroblasts and neocollagen on day 14. No abnormalities were observed in Group 1000 and 2000 of TEM. Levels of IL-1\u03b1 and TNF-\u03b1 increased at 12\u00a0h and decreased to baseline on day 3. Levels of IL-1\u03b2 increased at 12\u00a0h and decreased to baseline on day 7. Levels of IL-8 increased on day 1 and decreased to baseline on day 3.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>YAG laser vitreolysis is safe when the distance is more than 2\u00a0mm from ablation point to the lens and the retina, and the total energy is less than 2000\u00a0mJ for one treatment procedure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s10792-023-02858-0","type":"journal-article","created":{"date-parts":[[2023,9,4]],"date-time":"2023-09-04T08:07:33Z","timestamp":1693814853000},"page":"4585-4593","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Safety of YAG laser vitreolysis for intraocular tissues: analysis of postoperative complications"],"prefix":"10.1007","volume":"43","author":[{"given":"Jiannan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tingting","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenxue","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shaomin","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,9,4]]},"reference":[{"key":"2858_CR1","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1097\/00006982-200202000-00001","volume":"22","author":"J Sebag","year":"2002","unstructured":"Sebag J (2002) Is pharmacologic vitreolysis brewing? Retina 22:1\u20133. https:\/\/doi.org\/10.1097\/00006982-200202000-00001","journal-title":"Retina"},{"key":"2858_CR2","doi-asserted-by":"publisher","first-page":"295","DOI":"10.3109\/08820538.2010.518865","volume":"25","author":"MA Rheaume","year":"2010","unstructured":"Rheaume MA, Vavvas D (2010) Pharmacologic vitreolysis. Semin Ophthalmol 25:295\u2013302. https:\/\/doi.org\/10.3109\/08820538.2010.518865","journal-title":"Semin Ophthalmol"},{"key":"2858_CR3","volume-title":"Vitreous floaters","author":"R Bergstrom","year":"2018","unstructured":"Bergstrom R, Czyz CN (2018) Vitreous floaters. StatPearls, Treasure Island"},{"key":"2858_CR4","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.ajo.2011.01.026","volume":"152","author":"AM Wagle","year":"2011","unstructured":"Wagle AM, Lim WY, Yap TP, Neelam K, Au Eong KG (2011) Utility values associated with vitreous floaters. Am J Ophthalmol 152:60\u201365-e1. https:\/\/doi.org\/10.1016\/j.ajo.2011.01.026","journal-title":"Am J Ophthalmol"},{"key":"2858_CR5","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1755-3768.2009.01682.x","volume":"89","author":"S Schulz-Key","year":"2011","unstructured":"Schulz-Key S, Carlsson JO, Crafoord S (2011) Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction. Acta Ophthalmol 89:159\u2013165. https:\/\/doi.org\/10.1111\/j.1755-3768.2009.01682.x","journal-title":"Acta Ophthalmol"},{"key":"2858_CR6","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1111\/j.1755-3768.2009.01682.x","volume":"89","author":"S Schulz-Key","year":"2015","unstructured":"Schulz-Key S, Carlsson JO, Crafoord S (2015) Longterm follow-up of pars plana vitrectomy for vitreous floaters: complications, outcomes and patient satisfaction. Acta Ophthalmol 89:159\u2013165","journal-title":"Acta Ophthalmol"},{"key":"2858_CR7","doi-asserted-by":"publisher","first-page":"1055","DOI":"10.1097\/IAE.0000000000000063","volume":"34","author":"JO Mason","year":"2014","unstructured":"Mason JO, Albert MA, Feist RM et al (2014) Safety, efficacy, and quality of life following sutureless vitrectomy for symptomatic vitreous floaters. Retina 34:1055\u20131061","journal-title":"Retina"},{"key":"2858_CR8","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1097\/IAE.0000000000000065","volume":"34","author":"J Sebag","year":"2014","unstructured":"Sebag J, Yee KMP, Wa CA et al (2014) Vitrectomy for floaters: prospective efficacy analyses and retrospective safety profile. Retina 34:1062\u20131068","journal-title":"Retina"},{"key":"2858_CR9","doi-asserted-by":"publisher","first-page":"995","DOI":"10.1016\/j.ajo.2011.01.005","volume":"151","author":"HS Tan","year":"2011","unstructured":"Tan HS, Mura M, Oberstein S, Bijl HM (2011) Safety of vitrectomy for floaters. Am J Ophthalmol 151:995\u2013998","journal-title":"Am J Ophthalmol"},{"key":"2858_CR10","unstructured":"Specialists ASoR (2016) ASRS preferences and trends membership survey. Stone TW (eds) American Society of Retina Specialists, Chicago, IL"},{"key":"2858_CR11","first-page":"15","volume":"280","author":"T Vandorselaer","year":"2001","unstructured":"Vandorselaer T, Van De Velde F, Tassignon MJ (2001) Eligibility criteria for Nd-YAG laser treatment of highly symptomatic vitreous floaters. Bull Soc Belge Ophtalmol 280:15\u201319","journal-title":"Bull Soc Belge Ophtalmol"},{"key":"2858_CR12","doi-asserted-by":"publisher","first-page":"918","DOI":"10.1001\/jamaophthalmol.2017.2388","volume":"135","author":"CP Shah","year":"2017","unstructured":"Shah CP, Heier JS (2017) YAG laser vitreolysis vs sham YAG vitreolysis for symptomatic vitreous floaters: a randomized clinical trial. JAMA Ophthalmol 135:918\u2013923. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.2388","journal-title":"JAMA Ophthalmol"},{"key":"2858_CR13","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1007\/s40123-021-00422-6","volume":"11","author":"T Lin","year":"2022","unstructured":"Lin T, Li T, Zhang X, Hui Y, Moutari S, Pazo EE et al (2022) The efficacy and safety of YAG laser vitreolysis for symptomatic vitreous floaters of complete PVD or non-PVD. Ophthalmol Ther 11:201\u2013214. https:\/\/doi.org\/10.1007\/s40123-021-00422-6","journal-title":"Ophthalmol Ther"},{"key":"2858_CR14","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1007\/s12325-020-01261-w","volume":"37","author":"A Katsanos","year":"2020","unstructured":"Katsanos A, Tsaldari N, Gorgoli K, Lalos F, Asproudis I (2020) Safety and efficacy of YAG laser vitreolysis for the treatment of vitreous floaters: an overview. Adv Ther 37:1319\u20131327","journal-title":"Adv Ther"},{"key":"2858_CR15","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1016\/j.ajo.2014.10.006","volume":"159","author":"LA Cowan","year":"2015","unstructured":"Cowan LA, Khine KT, Chopra V, Fazio DT, Francis BA (2015) Refractory open-angle glaucoma after neodymium\u2013yttrium\u2013aluminum\u2013garnet laser lysis of vitreous floaters. Am J Ophthalmol 159:138\u2013143. https:\/\/doi.org\/10.1016\/j.ajo.2014.10.006","journal-title":"Am J Ophthalmol"},{"key":"2858_CR16","doi-asserted-by":"publisher","first-page":"956","DOI":"10.1111\/ceo.13190","volume":"46","author":"R O'Day","year":"2018","unstructured":"O\u2019Day R, Cugley D, Chen C, Fabinyi D (2018) Bilateral posterior capsule injury after Nd:YAG laser vitreolysis: unintended consequence of floaters treatment. Clin Exp Ophthalmol 46:956\u2013958. https:\/\/doi.org\/10.1111\/ceo.13190","journal-title":"Clin Exp Ophthalmol"},{"key":"2858_CR17","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1136\/bjophthalmol-2016-309005","volume":"101","author":"EH Koo","year":"2017","unstructured":"Koo EH, Haddock LJ, Bhardwaj N, Fortun JA (2017) Cataracts induced by neodymium\u2013yttrium\u2013aluminium\u2013garnet laser lysis of vitreous floaters. Br J Ophthalmol 101:709\u2013711. https:\/\/doi.org\/10.1136\/bjophthalmol-2016-309005","journal-title":"Br J Ophthalmol"},{"key":"2858_CR18","doi-asserted-by":"publisher","first-page":"e214","DOI":"10.3928\/23258160-20181101-21","volume":"49","author":"KH Huang","year":"2018","unstructured":"Huang KH, Weng TH, Chen YJ, Chang YH (2018) Iatrogenic posterior lens capsule rupture and subsequent complications due to Nd:YAG laser vitreolysis for vitreous floaters: a case report. Ophthalmic Surg Lasers Imaging Retina 49:e214\u2013e217. https:\/\/doi.org\/10.3928\/23258160-20181101-21","journal-title":"Ophthalmic Surg Lasers Imaging Retina"},{"key":"2858_CR19","doi-asserted-by":"publisher","first-page":"321","DOI":"10.1159\/000477159","volume":"8","author":"IT Sun","year":"2017","unstructured":"Sun IT, Lee TH, Chen CH (2017) Rapid cataract progression after Nd:YAG vitreolysis for vitreous floaters: a case report and literature review. Case Rep Ophthalmol 8:321\u2013325. https:\/\/doi.org\/10.1159\/000477159","journal-title":"Case Rep Ophthalmol"},{"key":"2858_CR20","doi-asserted-by":"publisher","first-page":"973","DOI":"10.1001\/jamaophthalmol.2017.2477","volume":"135","author":"P Hahn","year":"2017","unstructured":"Hahn P, Schneider EW, Tabandeh H, Wong RW, Emerson GG (2017) Reported complications following laser vitreolysis. JAMA Ophthalmol 135:973\u2013976. https:\/\/doi.org\/10.1001\/jamaophthalmol.2017.2477","journal-title":"JAMA Ophthalmol"},{"key":"2858_CR21","doi-asserted-by":"publisher","first-page":"e149","DOI":"10.5301\/ejo.5000854","volume":"26","author":"R Noristani","year":"2016","unstructured":"Noristani R, Schultz T, Dick HB (2016) Cataract formation after YAG laser vitreolysis: importance of femtosecond laser anterior capsulotomies in perforated posterior capsules. Eur J Ophthalmol 26:e149\u2013e151. https:\/\/doi.org\/10.5301\/ejo.5000854","journal-title":"Eur J Ophthalmol"},{"key":"2858_CR22","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1016\/j.ophtha.2020.10.026","volume":"128","author":"RA Shields","year":"2021","unstructured":"Shields RA, Cheng OT, Wolfe JD (2021) Iatrogenic vitreous hemorrhage, subretinal hemorrhage, and branch retinal vein occlusion after YAG laser vitreolysis for symptomatic vitreous floaters. Ophthalmology 128:616. https:\/\/doi.org\/10.1016\/j.ophtha.2020.10.026","journal-title":"Ophthalmology"},{"key":"2858_CR23","doi-asserted-by":"publisher","first-page":"610","DOI":"10.3928\/23258160-20211014-02","volume":"52","author":"RA Shields","year":"2021","unstructured":"Shields RA, Cheng OT, Ruby AJ, Williams GA, Wolfe JD (2021) Retinal complications after yttrium\u2013aluminum\u2013garnet laser vitreolysis for vitreous floaters. Ophthal Surg Lasers Imaging Retina 52:610\u2013613. https:\/\/doi.org\/10.3928\/23258160-20211014-02","journal-title":"Ophthal Surg Lasers Imaging Retina"},{"key":"2858_CR24","doi-asserted-by":"publisher","DOI":"10.1177\/11206721211008036","author":"BG Garcia","year":"2021","unstructured":"Garcia BG, Orduna Magan C, Alvarez-Peregrina C, Villa-Collar C, Sanchez-Tena MA (2021) Nd:YAG laser vitreolysis and health-related quality of life in patients with symptomatic vitreous floaters. Eur J Ophthalmol. https:\/\/doi.org\/10.1177\/11206721211008036","journal-title":"Eur J Ophthalmol"},{"key":"2858_CR25","doi-asserted-by":"publisher","first-page":"e248937","DOI":"10.1136\/bcr-2022-248937","volume":"15","author":"E de Vries","year":"2022","unstructured":"de Vries E, Faraj C, Gerbrandy F, Hulsman C (2022) Secondary open-angle glaucoma following YAG-laser vitreolysis. BMJ Case Rep 15:e248937. https:\/\/doi.org\/10.1136\/bcr-2022-248937","journal-title":"BMJ Case Rep"},{"key":"2858_CR26","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1007\/BF02143063","volume":"224","author":"HL Little","year":"1986","unstructured":"Little HL, Jack RL (1986) Q-switched neodymium: YAG laser surgery of the vitreous. Graefes Arch Clin Exp Ophthalmol 224:240\u2013246","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"2858_CR27","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1186\/s12886-020-01428-7","volume":"20","author":"X Liu","year":"2020","unstructured":"Liu X, Wang Q, Zhao J (2020) Acute retinal detachment after Nd:YAG treatment for vitreous floaters and postertior capsule opacification: a case report. BMC Ophthalmol 20:157. https:\/\/doi.org\/10.1186\/s12886-020-01428-7","journal-title":"BMC Ophthalmol"},{"key":"2858_CR28","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1038\/sj.eye.6700026","volume":"16","author":"YM Delaney","year":"2002","unstructured":"Delaney YM, Oyinloye A, Benjamin L (2002) Nd:YAG vitreolysis and pars plana vitrectomy: surgical treatment for vitreous floaters. Eye 16:21","journal-title":"Eye"},{"key":"2858_CR29","doi-asserted-by":"publisher","first-page":"267","DOI":"10.1007\/BF00417297","volume":"199","author":"H Freyler","year":"1976","unstructured":"Freyler H, Arnfelser H, Weiss H (1976) Experimental ultrasonography of the rabbit eye Albrecht Von Graefes Archiv F\u00fcr Klinische Und Experimentelle Ophthalmologie 199:267\u2013275","journal-title":"Experimental ultrasonography of the rabbit eye Albrecht Von Graefes Archiv F\u00fcr Klinische Und Experimentelle Ophthalmologie"},{"key":"2858_CR30","volume-title":"Basic Human Immunology","author":"DP Stites","year":"1991","unstructured":"Stites DP, Terr AI 1991 Basic human immunology. Prentice-Hall International Inc, Upper Saddle River"},{"key":"2858_CR31","first-page":"2120","volume":"33","author":"LN Fleisher","year":"1992","unstructured":"Fleisher LN, Ferrell JB, Mcgahan MC (1992) Synergistic uveitic effects of tumor necrosis factor-alpha and interleukin-1 beta. Invest Ophthalmol Vis 33:2120\u20132127","journal-title":"Invest Ophthalmol Vis"},{"key":"2858_CR32","doi-asserted-by":"publisher","unstructured":"Wong GG, Clark SC (1988) Multiple actions of interleukin 6 within a cytokine network. Immunol Today 9:137\u20139. https:\/\/doi.org\/10.1016\/0167-5699(88)91200-5","DOI":"10.1016\/0167-5699(88)91200-5"},{"key":"2858_CR33","doi-asserted-by":"publisher","first-page":"929","DOI":"10.3109\/02713688709034861","volume":"6","author":"P Bhattacherjee","year":"1987","unstructured":"Bhattacherjee P, Henderson B (1987) Inflammatory responses to intraocularly injected interleukin 1. Curr Eye Res 6:929\u2013934","journal-title":"Curr Eye Res"}],"container-title":["International Ophthalmology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02858-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10792-023-02858-0\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10792-023-02858-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,12,15]],"date-time":"2023-12-15T15:05:14Z","timestamp":1702652714000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10792-023-02858-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,9,4]]},"references-count":33,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["2858"],"URL":"https:\/\/doi.org\/10.1007\/s10792-023-02858-0","relation":{},"ISSN":["1573-2630"],"issn-type":[{"value":"1573-2630","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,9,4]]},"assertion":[{"value":"24 November 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 August 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 September 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All authors declare that they have no conflict of interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interests"}}]}}